Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis
Sponsor: Bristol-Myers Squibb
Check if you qualify for this plaque psoriasis clinical trial in Birmingham, AL
If you're searching for plaque psoriasis treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.